学会家庭规划临床建议:妊娠14 0/7至27 6/7周药物流产——与母胎医学会联合制定
该临床建议系统检索2008至2022年PubMed文献,针对妊娠14 0/7至27 6/7周药物流产,重点评价米非司酮-米索前列醇及单用米索前列醇方案。建议指出米非司酮200 mg口服预处理可提高24或48小时完全流产效果,并涉及米索前列醇剂量、途径、间隔及特殊人群个体化用药。
要点
- 米非司酮200 mg口服后使用米索前列醇,较单用米索前列醇提高24或48小时完全流产效果。
- 米非司酮不可及时,单次剂量至少200 mcg的多种米索前列醇方案有效。
- 有两次及以上剖宫产史者使用米索前列醇,子宫破裂风险较一次或无剖宫产史者升高但总体仍低。
核心结论
- 米非司酮200 mg口服后使用米索前列醇可提高24或48小时完全流产效果,单用米索前列醇在米非司酮不可及时仍有效。
研究设计与样本
- 学会家庭规划与母胎医学会联合制定的临床建议,系统检索2008至2022年PubMed文章并查阅纳入文献的参考文献列表。
主要发现
- 多项随机试验显示,妊娠14 0/7至27 6/7周药物流产中,米非司酮200 mg口服后使用米索前列醇较单用米索前列醇提高24或48小时完全流产效果。
- 研究持续评估米索前列醇的不同剂量、途径和给药间隔。
- 米非司酮不可及时,单次剂量至少200 mcg或以上的多种米索前列醇方案有效。
- 辅助性渗透性扩张器获益有限。
- 有两次及以上剖宫产史者使用米索前列醇,子宫破裂风险较一次或无剖宫产史者升高,但风险仍低。
关键数值与推荐
- 米非司酮200 mg口服后使用米索前列醇,较单用米索前列醇提高24或48小时完全流产效果。
- 米非司酮不可及时,单次剂量至少200 mcg或以上的米索前列醇方案有效。
- 在资源有限环境或妊娠24 0/7周及以后(或等效子宫大小)可考虑减少米索前列醇剂量。
- 有两次及以上剖宫产史者使用米索前列醇与子宫破裂风险升高相关,但风险仍低。
临床怎么用
- 应个体化护理,考虑在资源有限环境或妊娠24 0/7周及以后(或等效子宫大小)减少米索前列醇剂量。
- 多数避孕措施可在流产期间或流产后立即开始。
- 经过适当培训和认证的高级实践临床医生可在当地法规和执照范围内、具备适当后备支持的情况下提供妊娠14 0/7至27 6/7周药物流产。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The objective of this Clinical Recommendation is to review relevant literature and provide evidence-based recommendations for medication abortion between 14 0/7 and 27 6/7 weeks of gestation, with a focus on mifepristone-misoprostol and misoprostol-only regimens. We systematically reviewed PubMed articles published between 2008 and 2022 and reviewed reference lists of included articles to identify additional publications. See Search Strategy for more details. Several randomized trials of medication abortion between 14 0/7 and 27 6/7 weeks of gestation demonstrate that mifepristone 200 mg orally before misoprostol increases effectiveness (complete abortion at 24 or 48 hours) compared to misoprostol only. Studies continue to evaluate different doses, routes, and dosing intervals for misoprostol. If mifepristone is unavailable, several misoprostol regimens with individual doses of at least 200 mcg or more are effective. Adjunctive osmotic dilators are of limited benefit. It is important to individualize care, with consideration to reducing misoprostol dose in low-resource settings or at 24 0/7 weeks of gestation or later (or equivalent uterine size). Misoprostol in the setting of two or more previous cesarean sections is associated with increased risk of uterine rupture compared to one or none, but risk remains low. Most contraceptives can be started during or immediately following abortion. Appropriately trained and credentialed advanced practice clinicians can provide medication abortion between 14 0/7 and 27 6/7 weeks of gestation with appropriate backup within the confines of local regulations and licensure.
引用
- Zwerling B, Edelman A, Jackson A, et al. Society of Family Planning Clinical Recommendation: Medication abortion between 14 0/7 and 27 6/7 weeks of gestation: Jointly developed with the Society for Maternal-Fetal Medicine. Am J Obstet Gynecol. 2023. PMID: 37821258. doi:10.1016/j.ajog.2023.09.097
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。